Showing 1 - 5 results of 5 for search 'Lujia Sun', query time: 0.03s Refine Results
  1. 1
    Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines

    Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines by Qiao Wang, Lujia Sun, Shibo Jiang

    Published 2023-03-01
    Get full text
    Article
  2. 2
    Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines

    Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza va... by Pan Huang, Lujia Sun, Jinhao Li, Qingyi Wu, Nima Rezaei, Shibo Jiang, Chungen Pan

    Published 2023-06-01
    Get full text
    Article
  3. 3
    An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen

    An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen by Xinling Wang, Lujia Sun, Zezhong Liu, Lixiao Xing, Yun Zhu, Wei Xu, Shuai Xia, Lu Lu, Shibo Jiang

    Published 2023-12-01
    Get full text
    Article
  4. 4
    An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane

    An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane by Chao Wang, Qing Li, Lujia Sun, Xinling Wang, Huan Wang, Wenpeng Zhang, Jiahui Li, Yang Liu, Lu Lu, Shibo Jiang

    Published 2023-04-01
    Get full text
    Article
  5. 5
    A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike protein

    A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike protein by Songyi Xue, Xinling Wang, Lei Wang, Wei Xu, Shuai Xia, Lujia Sun, Shaohui Wang, Ning Shen, Ziqi Yang, Bo Huang, Sihao Li, Chuanhai Cao, Laurent Calcul, Xingmin Sun, Lu Lu, Jianfeng Cai, Shibo Jiang

    Published 2022-09-01
    Get full text
    Article

Search Tools: